Chemical Computing Group Awards Bursaries at Spring MGMS Meeting in Bristol, UK

MONTREAL and BRISTOL, April 4, 2002

Chemical Computing Group AG. (CCG) is pleased to announce its support of the 2002 Molecular Graphics and Modelling Society's (MGMS) Spring Meetingat the University of Bristol, UK, which is dedicated to the memory of Prof Peter Kollman. CCG has financed the award of bursaries enabling ten students to attend and present theirwork at the meeting. Each student will also be awarded a free copy of CCG's MOE software with which to continue their studies. The list of awardees is given in the Appendix below.

"An important role of the MGMS is to nurture up-and-coming talent and the committee would like to thank the CCG for their generous donation of ten student bursaries for the MGMS International Conference in memory of Peter Kollman," said Dr Catherine Burt, Chairperson of MGMS. "I came across Peter at my first ever MGMS conference when I was a student. He was an inspirational scientist and a wonderful mentor so it is very appropriate that this meeting has been dedicated to his memory and that young scientists have been given the opportunity to attend."

Bill Hayden, CCG's Vice President of Marketing and Sales, said "CCG is delighted to be able to support the MGMS meeting in this way. Today's students represent the future of our science and industry and their work should be encouraged and nurtured as much as possible. Organisations such as the MGMS have a vital role to play in this and we are happy to be able to help."

ABOUT CCG:
Chemical Computing Group (http://www.chemcomp.com) develops and markets MOE, the Molecular Operating Environment, a leading application for chemical researchers in the pharmaceutical and biotechnology fields. Its built-in applications cover the spectrum of drug discovery including: Protein/Homology modeling, High Throughput Screening, Combinatorial Library Design, Modeling/Simulations and Methods Development. MOEs unique architecture and platform independence allows it to be used corporate-wide by a variety of researchers - from methods developers to computational experts to medicinal chemists. Its customers include a worldwide roster of leading pharmaceutical and biotechnology companies.

For further information, contact Dr Steve Maginn, Chemical Computing Group, St Johns Innovation Centre, Cowley Road, Cambridge CB4 0WS, UK; phone +44 (0)1440 760953; e-mail

APPENDIX

• James Bradford, School of Biochemistry and Molecular Biology, University of Leeds Leeds LS2 9JT, UK contribution title: A NOVEL MACHINE VISION BASED ALGORITHM FOR MACROMOLECULAR DOCKING
• Diego Dal Ben, Molecular Modeling Section Department of Pharmaceutical Sciences University of Padova, Via Marzolo, 5 35131 Padova, Italy contribution title: RATIONAL DESIGN OF NEW COMPETITIVE INHIBITORS OF HUMAN CK2 ACTIVITY
• Laura De Luca, Dipartimento Farmaco-Chimico Universita'degli Studi di Messina Viale Annunziata 98168 Messina, Italy contribution title: HOMOLOGY MODELING OF AMPA RECEPTORS: ROUTE TO THE IDENTIFICATION OF NONCOMPETITIVE ANTAGONISTS BINDING SITE.
• Serena Donnini, Dept. of Biochemistry University of Oulu P.O. Box 3000 FIN-90014 Oulu, Finland contribution title: PROTEIN-LIGAND AFFINITY CALCULATIONS
• Christina Grindon, School of Pharmaceutical Sciences University of Nottingham University Park Nottingham NG7 2RD, UK contribution title: STRUCTURE AND STABILITY OF GUANINE AND INOSINE QUADRUPLEXES
• Stewart Kirton, Biological NMR Centre Maurice Shock Building University of Leicester University Road Leicester LE1 7RH, UK contribution title: IMPACT OF INCORPORATING CYP 2C5 CRYSTAL STRUCTURE INTO THE COMPARATIVE MODELLING OF CYP 2D6
• Sara Nunez, Dept. of Chemistry, University of Manchester Manchester M13 9PL, UK contribution title: THEORETICAL STUDY OF THE PROTEIN TRANSFER STEP IN METHYL AMINE DEHYDROGENASE (MADH) USING MOLECULAR DYNAMICS (MD), HYBRID QM/MM AND VARIATIONAL TRANSITION STATE THEORY WITH TUNNELLING CORRECTIONS
• Amesh Patel, Laboratory of Biophysics and Surface Analysis School of Pharmaceutical Sciences Boots Building University of Nottingham University Park Nottingham NG7 2RD, UK contribution title: DYNAMIC FORCE SPECTROSCOPY: A POTENTIAL TOOL FOR RATIONAL DRUG DESIGN - A STREPTAVIDIN-BIOTIN MODEL
• Olli Pentikinen , bo Akademi University P.O.Box 66 FIN-20521 Turku, Finland contribution title: SELECTIVE AGONIST BINDING OF AMPA AND KAINATE RECEPTORS
• Knut Teigen Department of Biochemistry and Molecular Biology University of Bergen Aarstadveien 19 5009 Bergen, Norway contribution title: THE CONFORMATION AND DYNAMICS OF THE COMPLEXES OF SUBSTRATES AND THE AROMATIC AMINO ACID HYDROXYLASES